- Hardcover: 342 pages
- Publisher: Jenny Stanford Publishing; 1 edition (March 18, 2020)
- Language: English
- ISBN-10: 9814800546
- ISBN-13: 978-9814800549
- Product Dimensions: 6 x 9 inches
- Shipping Weight: 3.5 ounces
- Customer Reviews:
- Amazon Best Sellers Rank: #8,991,303 in Books (See Top 100 in Books)
Nanoparticle Drug Delivery Systems for Cancer Treatment 1st Edition
Use the Amazon App to scan ISBNs and compare prices.
Enter your mobile number or email address below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
To get the free app, enter your mobile phone number.
“This precious book provides a complete update to the most recent advances in the application and characterization of bionanomaterials in personalized medicine, including the molecular targeting of cancer. The authors have done a marvelous job. This reference is an exceptional source for scientists and students.” Prof. Hosam G. Abdelhady, Wayne State University, USA
“This book is a valuable research reference and an excellent addition to the library of any scientist working in the field of drug delivery for cancer treatment. It provides a comprehensive overview of nanomedicine and highlights the recent advances in their preparation, delivery strategies, assessment techniques, and specific clinical applications. The chapters explore the current state of the field and provide future perspectives and potential for clinical translation.” Dr. Ali Tehrani, American University of Beirut, Lebanon
“This timely collection contains cutting-edge research in the fields of nanoparticles, drug discovery, and cancer therapy, contributed by 10 international expert teams. It serves as a great reference for basic, translational, and clinical researchers.” Prof. Q. Ping Dou, Wayne State University, USA
About the Author
Hala Gali-Muhtasib is a tenured professor in the Department of Biology and director of the Center for Drug Discovery, American University of Beirut, Lebanon. She earned her PhD from Kansas State University, USA, and is a prominent scholar with outstanding contributions to the study of the role of natural and novel synthetic compounds in cancer therapy. She has published more than 100 research articles in peer-reviewed journals and is a recipient of five international/regional research awards for her contributions to anticancer drug therapy.
Racha Chouaib is a researcher at the Center for Drug Discovery, American University of Beirut, and assistant professor at the Lebanese International University and the Lebanese University. She received her PhD from the University of Montpellier, France, in 2016. She is a specialist in molecular genetics (RNA field) and has contributed to studies on the role of drug delivery systems in cancer therapy. She has published several research articles in peer-reviewed journals.
|5 star (0%)||0%|
|4 star (0%)||0%|
|3 star (0%)||0%|
|2 star (0%)||0%|
|1 star (0%)||0%|